Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2000
11/08/2000CN1272500A Safflower total uranidin, its preparation and application
11/08/2000CN1272381A Shaoshangfu sukang ointment for curing burn
11/08/2000CN1272380A Plaster for curing mastosis
11/08/2000CN1272370A Eye ointment for curing myopia and its production process
11/08/2000CN1272367A Preparation of body-nourishing honey pill food
11/08/2000CN1272362A Selective antibiotic composition
11/08/2000CN1272337A Kelp product (II) and its production method and application
11/08/2000CN1058190C Memory oral liquor
11/08/2000CN1058187C Traumatic injury plaster
11/08/2000CN1058186C Plaster for periarthritis of shoulder joint
11/08/2000CN1058175C Traditional Chinese medicine for treating constipation
11/08/2000CN1058169C Weight-reducing health oral liquor
11/08/2000CN1058167C Aconite oral liquor and preparation method thereof
11/08/2000CN1058166C Drug for curing leukopenia and radiation damage
11/08/2000CN1058164C Tinture for curing traumatic injury
11/08/2000CN1058156C Osteophytosis pill and its preparation method
11/08/2000CN1058155C Medicinal liquid for curing bromhidrosis
11/08/2000CN1058153C Compound metronidazole suppository
11/08/2000CN1058150C Topical aromatic releasing compositions
11/08/2000CN1058148C Process for preparing Chinese traditional medicine spongy pill
11/08/2000CN1058138C Betel chewing gum
11/07/2000US6143799 Use of borate-polyol complexes in ophthalmic compositions
11/07/2000US6143797 Use of sodium 2-mercaptoethanesulfonate in surgery
11/07/2000US6143795 Stable mitoxantrone solutions
11/07/2000US6143794 Topical formulations for the treatment of nail fungal diseases
11/07/2000US6143793 Use of hydrophilic penetration agents in dermatological compositions for the treatment of onychomycoses, and corresponding compositions
11/07/2000US6143785 Inflammatory bowel disease with alkanoyl carnitine in solution
11/07/2000US6143778 Composition with buffers and nonionic surfactants
11/07/2000US6143775 Physical form of zafirlukast; asthma
11/07/2000US6143735 Enhancing blood circulation promoter, comprising combining in oral administration unit does form effective amount of vitamin e and carrier or adjuvant, wherein blood circulation promoter is an ester of salicylic acid
11/07/2000US6143729 Compounds related to the amidinium family, pharmaceutical compositions containing same, and uses thereof
11/07/2000US6143716 Liposomal peptide-lipid conjugates and delivery using same
11/07/2000US6143501 Inducing artificial three-dimensional tissues using cell interaction systems such that cultures possessing or developing extracellular matrix are linked via membranes, or are in direct contact with or are mixed with each other
11/07/2000US6143353 Hydrophobic, storage stability,
11/07/2000US6143329 Aqueous-based pharmaceutical composition
11/07/2000US6143328 Sustained release compositions and a method of preparing pharmaceutical compositions
11/07/2000US6143327 Multilayer coatings
11/07/2000US6143326 Therapy for osteoporosis
11/07/2000US6143325 Ph modulation; sustained release
11/07/2000US6143324 Free-flowable directly compressible starch as binder, disintegrant and filler for compression tablets and hard gelatine capsules
11/07/2000US6143323 Containing n-(4-isopropylcyclohexanecarbonyl)phenylalanine inhydroxypropyl cellulose
11/07/2000US6143322 Method of treating humans with opioid formulations having extended controlled release
11/07/2000US6143321 Liposomes containing active agents
11/07/2000US6143320 Method for the application of an active substance patch for controlling or alleviating an addiction
11/07/2000US6143319 Transdermal therapeutic system containing estradiol
11/07/2000US6143317 Active substance plasters
11/07/2000US6143316 Digestible pouch and method for administering medications to an animal
11/07/2000US6143315 Biochemical contact lens for treating injured corneal tissue
11/07/2000US6143314 Thermoplastic resin
11/07/2000US6143302 Headache and colic relief composition with asafetida and method of use thereof
11/07/2000US6143290 Tumor regression by adenovirus expression of wild-type p53
11/07/2000US6143287 Applying a mixture of liposome and phthalocyanine; applying light source
11/07/2000US6143279 Uridine 5'-diphosphate and analogs useful for treating lung diseases
11/07/2000US6143278 Topical administration of opioid analgesic agent in admixture with skin or mucosal specific penetration enhancer to produce localized analgesic effect in skin or mucosal tissue without transdermal migration of opiod agent
11/07/2000US6143276 Methods for delivering bioactive agents to regions of elevated temperatures
11/07/2000US6143211 Process for preparing microparticles through phase inversion phenomena
11/07/2000US6143204 Stabilization of iodopropynl compounds
11/07/2000US6142972 Method and apparatus for the delivery of elongate solid drug compositions
11/07/2000CA2046998C Method of producing liposomal products
11/07/2000CA2046893C Protein coupling to lipid vesicles
11/07/2000CA2023127C Composite film for surface treatment and manufacture method thereof
11/07/2000CA2011290C A moderated spun fibrous system and method of manufacture
11/07/2000CA2004598C Medicinal aerosol formulations
11/03/2000CA2270600A1 Method and formulations for the treatment of diseases, particularly those caused by human immunodeficiency virus and leishmania
11/02/2000WO2000065058A1 Method for down-regulating il5 activity
11/02/2000WO2000065030A2 Microencapsulated genetically engineered e. coli dh 5 cells for the removal of undesired electrolytes and/or metabolites
11/02/2000WO2000065024A2 Hyperbranched polymeric micelles for encapsulation and delivery of hydrophobic molecules
11/02/2000WO2000064954A1 Polymeric encapsulation system promoting angiogenesis
11/02/2000WO2000064940A1 Insulin crystals for pulmonary administration
11/02/2000WO2000064875A1 Method for pulvirizing to fine powder
11/02/2000WO2000064858A1 Bipolar lipids and their use for the delivery of bioactive substances
11/02/2000WO2000064778A1 Medicament carrier
11/02/2000WO2000064684A2 Method and device for labeling a two-dimensional polymer adhesive system, especially a transdermal therapeutic system
11/02/2000WO2000064575A1 Method for production of microcapsules
11/02/2000WO2000064552A1 A method of spray drying and a plant therefor as well as a particulate material obtained by the method
11/02/2000WO2000064520A1 Powder inhaler for combined medicament
11/02/2000WO2000064516A1 Controlled delivery of bisphosphonates
11/02/2000WO2000064484A2 Conjugate having a cleavable linkage for use in a liposome
11/02/2000WO2000064483A2 Releasable linkage and compositions containing same
11/02/2000WO2000064471A1 Model membrane systems
11/02/2000WO2000064470A1 A pharmaceutical formulation comprising a low molecular weight thrombin inhibitor and its prodrug
11/02/2000WO2000064450A1 Pharmaceutical composition
11/02/2000WO2000064447A1 Novel compositions comprising trimetrexate and methods of their synthesis and use
11/02/2000WO2000064444A1 Novel pharmaceutical compositions comprising 2-isoxazole-8-aminotetralin derivatives
11/02/2000WO2000064442A1 Novel anticoagulant injectable composition
11/02/2000WO2000064440A1 Treatment of and/or prophylaxis against brain and spinal cord injury
11/02/2000WO2000064436A1 Methods of delivery of cetyl myristoleate
11/02/2000WO2000064435A1 Percutaneous absorption preparations containing oxybutynin
11/02/2000WO2000064434A1 Percutaneous preparations containing oxybutynin
11/02/2000WO2000064433A1 Ketoprofen microgranules, preparation method and pharmaceutical compositions
11/02/2000WO2000064432A1 Ketoprofen microgranules, method for preparing same and pharmaceutical compositions
11/02/2000WO2000064429A1 Pharmaceutical composition effective against pathological conditions caused by bacteria, viruses, fungi, yeasts and protozoa
11/02/2000WO2000064427A2 Lamivudine containing pharmaceutical formulation
11/02/2000WO2000064426A2 Carnitine and inositol phosphate-containing composition useful as dietary supplement or drug
11/02/2000WO2000064419A1 Transdermal therapeutic system with a highly effective neuroleptic agent
11/02/2000WO2000064418A2 Transdermal therapeutic system with neutralized acrylic adhesive patch
11/02/2000WO2000064417A2 Inactivated microorganisms comprising substances having pharmacological activity
11/02/2000WO2000064416A2 Pharmaceutical formulation of tamoxifen citrate
11/02/2000WO2000064415A1 Method for producing a water-insoluble amorphous or partially amorphous controlled release matrix
11/02/2000WO2000064414A2 Solid pharmaceutical formulations of acid-sensitive proton-pump blockers
1 ... 2440 2441 2442 2443 2444 2445 2446 2447 2448 2449 2450 2451 2452 2453 2454 2455 2456 2457 2458 2459 2460 ... 2991